Fig. 9From: The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cellsIn vivo studies: effect of CEP-37440 on mice with SUM190 breast tumor xenografts. Mice were injected with 106 SUM190 cells in the mammary fat pad; when the breast tumor xenografts reached approximately 100Â mm3, treatment with 55Â mg/kg bid CEP-37440 began. Treatments with CEP-37440 were performed twice a day during 7Â weeks (35Â days of treatment). a Volumes of breast tumor xenografts in the control group (without treatment) or mice treated with 55Â mg/kg CEP-37440; b weights of the mice in the different groups. Standard errors (SE) are indicatedBack to article page